Apex Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-36,377	Closed	-$1.41M	–	258
2014 Q2	$1.41M	Buy	36,377 +5,136	+16%	+$200K	0.04%	181
2014 Q1	$1.31M	Buy	+31,241	New	+$1.31M	0.05%	184